Home Cart Sign in  
Chemical Structure| 535-83-1 Chemical Structure| 535-83-1

Structure of Trigonelline
CAS No.: 535-83-1

Chemical Structure| 535-83-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Trigonelline, a natural product isolated and purified from the seeds of Trigonella foenum-graecum L. with phytoestrogenic and antitumor effects, inhibits the adipogenesis by its influences on the expression PPARγ, which leads to subsequent down regulation of PPAR-γ mediated pathway during adipogenesis.

Synonyms: Trigenolline

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Trigonelline

CAS No. :535-83-1
Formula : C7H7NO2
M.W : 137.14
SMILES Code : O=C([O-])C1=CC=C[N+](C)=C1
Synonyms :
Trigenolline
MDL No. :MFCD00054262
InChI Key :WWNNZCOKKKDOPX-UHFFFAOYSA-N
Pubchem ID :5570

Safety of Trigonelline

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • PI3K

In Vitro:

Cell Line
Concentration Treated Time Description References
HepG2 and C2C12 cells 1 mM 24 hours Trigonelline did not increase NAD+ levels in cells with low NAPRT expression, indicating NAPRT dependency. Nat Metab. 2024 Mar;6(3):433-447
Primary myotubes from aged mice 1 mM 24 hours Trigonelline increased NAD+ levels in aged mouse primary myotubes, indicating its efficacy across species. Nat Metab. 2024 Mar;6(3):433-447
HSMMs (Primary human skeletal muscle myotubes) 315 µM (EC50) 24 hours Trigonelline increased NAD+ levels in control cells and rescued NAD+ deficiency in FK866-treated cells, demonstrating its role as an NAD+ precursor. Nat Metab. 2024 Mar;6(3):433-447
Cisplatin-resistant head and neck cancer cells (HN3-cisR, HN4-cisR, HN9-cisR) 100 µM 24 hours Trigonelline significantly decreased cellular glutathione (GSH) levels and caused lipid ROS accumulation Redox Biol. 2017 Apr;11:254-262
Rhizobium meliloti RCR2011 2.9 mM (0.5 g/L) 3 hours and 30 minutes To investigate the inducing effect of trigonelline on trc gene expression, results showed that trigonelline is a specific inducer of trc genes. Plant Cell. 1990 Dec;2(12):1157-1170
Head and neck cancer cells (HN3, HN4, HN9) 1–100 µM 72 hours Trigonelline reversed the ferroptosis resistance of Keap1-silenced and cisplatin-resistant HNC cells to artesunate Redox Biol. 2017 Apr;11:254-262

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6JRj mice Aged mice (20 months) Oral gavage or dietary supplementation 300 mg/kg Acute: 2 h or 16 h; Chronic: 5 days or 12 weeks Trigonelline increased NAD+ levels in liver, muscle, kidney, and blood, improved mitochondrial function, and enhanced muscle strength and fatigue resistance in aged mice. Nat Metab. 2024 Mar;6(3):433-447
BALB/c nude mice Head and neck cancer xenograft model Oral 50 mg/kg Daily, until treatment duration Trigonelline significantly inhibited in vivo tumor growth and reduced GSH levels in tumors Redox Biol. 2017 Apr;11:254-262

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02999152 Bone Metastasis ... More >> Malignant Hemopathy Less << Not Applicable Recruiting December 31, 2019 France ... More >> Institut de Cancérologie Lucien Neuwirth Recruiting Saint-Priest en Jarez, France, 42270 Principal Investigator: Nicolas Magné, PhD          Sub-Investigator: Guy De Laroche, MD          Sub-Investigator: Grégoire Pigne, MD          Sub-Investigator: Denis Guyotat, PhD          Sub-Investigator: Jérôme Cornillon, MD          Institut Gustave Roussy Not yet recruiting Villejuif, France, 94800 Contact: Valentine Martin, MD          Principal Investigator: Valentine Martin, MD          Sub-Investigator: Angela Boros, MD Less <<
NCT03166540 Diet Modification ... More >> Cardiovascular Risk Factor Nutritional and Metabolic Diseases Less << Not Applicable Completed - Italy ... More >> Department of Food and Drug, University of Parma Parma, Italy, 43125 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

7.29mL

1.46mL

0.73mL

36.46mL

7.29mL

3.65mL

72.92mL

14.58mL

7.29mL

References

 

Historical Records

Categories